FDA infant formula info
This article was originally published in The Tan Sheet
Executive Summary
Revamped 1CFSAN formula Web site features expanded, easy-to-find "frequently asked questions" section, including Q&As on DHA, ARA. Site, which includes "information about infant formula that may be helpful to industry, consumers, government agencies and other interested parties," launched Jan. 10 in effort to consolidate relevant material. Site now includes guidance documents, advisory committee meeting info and a section on exempt formulas...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.